Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alae Abbassi"'
Autor:
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise Halse, Severine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martin-Romano, Jean-Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amelie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel-Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurelien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean-Charles Soria, Christophe Massard, Aurelien Marabelle
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-14 (2022)
Abstract Background We aimed to determine the safety and efficacy of nintedanib, an oral anti-angiogenic tyrosine kinase inhibitor, in combination with pembrolizumab, an anti-PD1 immunotherapy, in patients with advanced solid tumors (PEMBIB trial; NC
Externí odkaz:
https://doaj.org/article/cc022ab82e6e4fd69d684a17c4dfa3ff
Autor:
François-Xavier Danlos, Matthieu Texier, Bastien Job, Severine Mouraud, Lydie Cassard, Capucine Baldini, Andrea Varga, Andrey A. Yurchenko, Audrey Rabeau, Stéphane Champiat, Diane Letourneur, Delphine Bredel, Sandrine Susini, Yuna Blum, Aurelien Parpaleix, Cedric Parlavecchio, Lambros Tselikas, Jean-Eudes Fahrner, Anne-Gaelle Goubet, Mathieu Rouanne, Saloomeh Rafie, Alae Abbassi, Ines Kasraoui, Marie Breckler, Siham Farhane, Samy Ammari, Salim Laghouati, Anas Gazzah, Ludovic Lacroix, Benjamin Besse, Nathalie Droin, Marc Deloger, Sophie Cotteret, Julien Adam, Laurence Zitvogel, Sergey I. Nikolaev, Nathalie Chaput, Christophe Massard, Jean-Charles Soria, Carlos Gomez-Roca, Gerard Zalcman, David Planchard, Aurelien Marabelle
Publikováno v:
Cancer Discovery
Cancer Discovery, 2023, pp.OF1-OF22. ⟨10.1158/2159-8290.CD-22-0886⟩
Cancer Discovery, 2023, pp.OF1-OF22. ⟨10.1158/2159-8290.CD-22-0886⟩
Cancer immunotherapy combinations have recently been shown to improve the overall survival of advanced mesotheliomas, especially for patients responding to those treatments. We aimed to characterize the biological correlates of malignant pleural meso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5017878bdc841681bdf4cd403e9f0c10
https://doi.org/10.1158/2159-8290.cd-22-0886
https://doi.org/10.1158/2159-8290.cd-22-0886
Autor:
Aurelien Marabelle, David Planchard, Gerard Zalcman, Carlos Gomez-Roca, Jean-Charles Soria, Christophe Massard, Nathalie Chaput, Sergey I. Nikolaev, Laurence Zitvogel, Julien Adam, Sophie Cotteret, Marc Deloger, Nathalie Droin, Benjamin Besse, Ludovic Lacroix, Anas Gazzah, Salim Laghouati, Samy Ammari, Siham Farhane, Marie Breckler, Ines Kasraoui, Alae Abbassi, Saloomeh Rafie, Mathieu Rouanne, Anne-Gaelle Goubet, Jean-Eudes Fahrner, Lambros Tselikas, Cedric Parlavecchio, Aurelien Parpaleix, Yuna Blum, Sandrine Susini, Delphine Bredel, Diane Letourneur, Stéphane Champiat, Audrey Rabeau, Andrey A. Yurchenko, Andrea Varga, Capucine Baldini, Lydie Cassard, Severine Mouraud, Bastien Job, Matthieu Texier, François-Xavier Danlos
Immuno-Histo-Chemistry scoring of baseline tumor biopsies according to their DCB status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d65585e010ecfe9fceb050412fe96a
https://doi.org/10.1158/2159-8290.22553458.v1
https://doi.org/10.1158/2159-8290.22553458.v1
Autor:
Aurelien Marabelle, David Planchard, Gerard Zalcman, Carlos Gomez-Roca, Jean-Charles Soria, Christophe Massard, Nathalie Chaput, Sergey I. Nikolaev, Laurence Zitvogel, Julien Adam, Sophie Cotteret, Marc Deloger, Nathalie Droin, Benjamin Besse, Ludovic Lacroix, Anas Gazzah, Salim Laghouati, Samy Ammari, Siham Farhane, Marie Breckler, Ines Kasraoui, Alae Abbassi, Saloomeh Rafie, Mathieu Rouanne, Anne-Gaelle Goubet, Jean-Eudes Fahrner, Lambros Tselikas, Cedric Parlavecchio, Aurelien Parpaleix, Yuna Blum, Sandrine Susini, Delphine Bredel, Diane Letourneur, Stéphane Champiat, Audrey Rabeau, Andrey A. Yurchenko, Andrea Varga, Capucine Baldini, Lydie Cassard, Severine Mouraud, Bastien Job, Matthieu Texier, François-Xavier Danlos
Cytotoxic response in tumor biopsies of patients with No DCB upon combination treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e42201830c3a43cbdca6da454c91cd
https://doi.org/10.1158/2159-8290.22553473.v1
https://doi.org/10.1158/2159-8290.22553473.v1
Autor:
Aurelien Marabelle, David Planchard, Gerard Zalcman, Carlos Gomez-Roca, Jean-Charles Soria, Christophe Massard, Nathalie Chaput, Sergey I. Nikolaev, Laurence Zitvogel, Julien Adam, Sophie Cotteret, Marc Deloger, Nathalie Droin, Benjamin Besse, Ludovic Lacroix, Anas Gazzah, Salim Laghouati, Samy Ammari, Siham Farhane, Marie Breckler, Ines Kasraoui, Alae Abbassi, Saloomeh Rafie, Mathieu Rouanne, Anne-Gaelle Goubet, Jean-Eudes Fahrner, Lambros Tselikas, Cedric Parlavecchio, Aurelien Parpaleix, Yuna Blum, Sandrine Susini, Delphine Bredel, Diane Letourneur, Stéphane Champiat, Audrey Rabeau, Andrey A. Yurchenko, Andrea Varga, Capucine Baldini, Lydie Cassard, Severine Mouraud, Bastien Job, Matthieu Texier, François-Xavier Danlos
Cancer immunotherapy combinations have recently been shown to improve the overall survival of advanced mesotheliomas, especially for patients responding to those treatments. We aimed to characterize the biological correlates of malignant pleural meso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9bfec93c15161b5905f0dca9ec88ae0
https://doi.org/10.1158/2159-8290.c.6534585.v1
https://doi.org/10.1158/2159-8290.c.6534585.v1
Autor:
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise Halse, Severine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martin-Romano, Jean-Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amelie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel-Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurelien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean-Charles Soria, Christophe Massard, Aurelien Marabelle
Publikováno v:
Journal of experimentalclinical cancer research : CR. 41(1)
Background We aimed to determine the safety and efficacy of nintedanib, an oral anti-angiogenic tyrosine kinase inhibitor, in combination with pembrolizumab, an anti-PD1 immunotherapy, in patients with advanced solid tumors (PEMBIB trial; NCT02856425
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f27be1ad43b2f56e556910061dfaaa
https://pubmed.ncbi.nlm.nih.gov/35794623
https://pubmed.ncbi.nlm.nih.gov/35794623